logo

For the Inventor, By the Inventor

San Mateo, CA, United States of America

Sciclone Pharmaceuticals, Inc.


USPTO Granted Patents = 21

% Expired Patents = 38.1



Trademarks = 1

Forward Citations = 162

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Cynthia W Tuthill (7 out of 8 patents)

silverMedal Alfred R Rudolph (7 out of 8 patents)

bronzeMedal Luigina Romani (2 out of 11 patents)

4.  Enrico Garaci (2 out of 14 patents)

5.  Guido Rasi (2 out of 3 patents)

6.  Francesco Bistoni (2 out of 6 patents)

7.  Paolo Di Francesco (2 out of 2 patents)

8.  David L Horwitz (2 out of 2 patents)

9.  Milton G Mutchnick (2 out of 6 patents)

10.  Paul B Chretien (2 out of 4 patents)

11.  Robert S King (1 out of 8 patents)

12.  Friedhelm Blobel (1 out of 3 patents)

13.  Paolo Carminati (1 out of 37 patents)

14.  Eric C Mossel (1 out of 1 patent)

15.  Clarence J Peters (1 out of 2 patents)


21 patents:

1. 9724395 - Treatment of cancer with immune stimulators (2017-08-08),
2. 8716012 - Alpha thymosin peptides as vaccine enhancers (2014-05-06),
3. 8389680 - [object Object] (2013-03-05),
4. 8207294 - [object Object] (2012-06-26),
5. 8193152 - Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds (2012-06-05),
6. 8163702 - Treatment of melanoma (2012-04-24),
7. 8029799 - Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma (2011-10-04),
8. 7906486 - Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa (2011-03-15),
9. 7897567 - Methods of protecting against radiation damage using alpha thymosin (2011-03-01),
10. 7297676 - Thymosin alpha 1 peptide/polymer conjugates (2007-11-20),
11. 7208167 - Treatment of hepatitis C with thymosin and peptide combination therapy (2007-04-24),
12. 7173013 - Treatment of tuberculosis using immunomodulator compounds (2007-02-06),
13. 6495521 - Combination therapy method for treating chronic hepatitis B (2002-12-17),
14. 6462017 - Method of reducing side effects of chemotherapy in cancer patients (2002-10-08),
15. 6288033 - Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir (2001-09-11),
Company Overview
Sciclone Pharmaceuticals, Inc. is a biopharmaceutical company based in San Mateo, California, focused on the development and commercialization of innovative therapies for cancer and other serious diseases. The company specializes in the research and development of novel compounds and has a strong emphasis on leveraging advanced technologies to enhance drug delivery and efficacy. Sciclone aims to address unmet medical needs through its commitment to scientific excellence and strategic partnerships within the healthcare sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

21 Patents

#42 in San Mateo, CA

#3,758 in California

#15,692 in US

#29,948 in the World

San Mateo, CA (US)
San Mateo, CA, United States of America

Sciclone Pharmaceuticals, Inc.

Forward Citations = 162

31 inventors:

goldMedal Cynthia W Tuthill (7 out of 8 patents)

silverMedal Alfred R Rudolph (7 out of 8 patents)

bronzeMedal Luigina Romani (2 out of 11 patents)

4.  Enrico Garaci (2 out of 14 patents)

5.  Guido Rasi (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sciclone Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/sciclone-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…